title: Practical guidelines for the use of NESP in treating renal anaemia.
authors.forename: P
authors.initials: P
authors.lastname: Aljama
authors.forename: J
authors.initials: J
authors.lastname: Bommer
authors.forename: B
authors.initials: B
authors.lastname: Canaud
authors.forename: F
authors.initials: F
authors.lastname: Carrera
authors.forename: K U
authors.initials: KU
authors.lastname: Eckardt
authors.forename: W H
authors.initials: WH
authors.lastname: Hörl
authors.forename: R T
authors.initials: RT
authors.lastname: Krediet
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
authors.forename: I C
authors.initials: IC
authors.lastname: Macdougall
authors.forename: B
authors.initials: B
authors.lastname: Wikström
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000068256:Darbepoetin alfa; D016903:Drug Monitoring; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D010530:Peritoneal Dialysis / Q000592:standards; D006435:Renal Dialysis / Q000592:standards
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa